Recent news on Zevalin

Promising new treatments for cancer and osteoporosis.  -  May 22, 2007
SlateTreatments: Two such radioactive-antibody cancer medications exist: Bexxar and Zevalin. As the drug Rituxan, which consists of the antibody without the

Slow reaction  -  May 16, 2007
South Bend Tribune,But the only two approved drugs that employ the technique -- Bexxar and Zevalin -- are being given to just a fraction of non-Hodgkin lymphoma patients

Lymphoma drug failure frustrates experts  -  May 3, 2007
White Rock Reviewer,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others — against some

Lymphoma Drug Failure Frustrates Experts  -  May 1, 2007
PhysOrg.com,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others - against some

Lymphoma Drug Failure Frustrates Experts  -  May 1, 2007
Wyoming News,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others _ against some

Lymphoma Drug Failure Frustrates Experts  -  Apr 30, 2007
phillyBurbs.com,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others , against some

HEALTHBEAT: Smart bombs for lymphoma underused  -  Apr 30, 2007
The Northwest Florida Daily News,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others, against some

Smart bombs for lymphoma underused  -  Apr 30, 2007
ABC7Chicago.com,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others -- against some

Lymphoma drug failure frustrates experts  -  Apr 30, 2007
Denver Post,Only two such drugs are sold today, the lymphoma fighters Zevalin and Bexxar. But more than half a dozen early stage studies of others—against some

'Smart bombs' for lymphoma underused  -  May 1, 2007
AZ Central.com,The issue: Despite research showing they work well, fewer than 10 percent of lymphoma patients who are candidates for Zevalin and Bexxar ever use them,

Editor's Mailbag  -  May 16, 2007
Mason City Globe Gazette,On May 2 and May 9, 2007, he received the Zevalin infusion at the Mayo Clinic in a special unit designed for these treatments. A CT scan on June 15, 2006,

Drug Safety Proposals and the Intrusion Of Federal Regulation into ...  -  May 11, 2007
American Enterprise Institute,Plenaxis, Zevalin, and Bexxar); (3) overdose and diversion: risk of fatal overdose, dangerous diversion, and sudden death that requires special handling

Biogen Idec Reports First Quarter 2007 Results  -  May 2, 2007
Genetic Engineering News (press release),29760 (196) Zevalin(R) 5603 5010 --------- --------- Total product revenues $484388 $406519 ========= ========= Numbers may not foot due to rounding.

Genentech tests stronger cancer drug, may boost sales  -  Apr 17, 2007
Financial Express.bd,Included in the old approach is Biogen Idec Inc.'s radiation-antibody combination Zevalin, which recorded $16.4 million in sales in its fourth year on the

Pharma Sector: Few Newsmakers Of The Week - AtheroGenics, Pain ...  -  Mar 24, 2007
Trading Markets,Last year, Zevalin pitched in sales of $17.76 million compared to $20.80 million in 2005. In sharp contrast, Rituxan garnered in US net sales of $2.05

New Indication for Pain  -  Mar 21, 2007
Motley Fool...antibodies that have made it to market, like GlaxoSmithKline's (NYSE: GSK) Bexxar or Biogen Idec's (Nasdaq: BIIB) Zevalin, have been commercial flops.

Tracon Licenses D93 Antibody From Micromet  -  Mar 18, 2007
BioWorld Online,Genentech Inc. and Biogen Idec Inc.), Zevalin (ibritumomab tiuxetan, Schering AG and Biogen Idec Inc.), Sutent (sunitinib, Pfizer Inc.),

Oncologic Appoints Stephen T. Isaacs as President and Chief ...  -  Mar 6, 2007
Business Wire (press release),...where they were part of the senior scientific team responsible for the successful development and clinical approval of the anti-cancer drug Zevalin®.

Company Profile for TRACON Pharmaceuticals, Inc.  -  Feb 9, 2007
Business Wire (press release),The management team has led or contributed to the development of six approved biopharmaceuticals: Rituxan®, Zevalin®, Viracept®, Targretin®, Macugen® and

Company Profile for Tracon Pharmaceuticals, Inc.  -  Feb 9, 2007
PharmaLive.com (press release),The management team has led or contributed to the development of six approved biopharmaceuticals: Rituxan(R), Zevalin(R), Viracept(R), Targretin(R),

Biogen Idec Reports Full Year and Fourth Quarter 2006 Results  -  Feb 15, 2007
American Digital Networks (press release),...including Amevive and our Bio 1 facility, and severance and restructuring charges related to the planned ZEVALIN(R) (ibritumomab tiuxetan) disposition.

Clinical Practice of Molecular Radiotherapy  -  Jan 31, 2007
Journal of Nuclear Medicine (subscription)Furthermore, the fairly recent Food and Drug Administration approval of 2 radiolabeled monoclonal antibodies, 90 Y-ibritumomab tiuxetan (Zevalin;

CHOP Plus Zevalin (REG) Therapy Shows Efficacy In Elderly Patients ...  -  Dec 25, 2006
Medical News Today (press release),Zevalin (90Y Ibritumomab Tiuxetan) treatment was given to patients as a first-line consolidation therapy after patients had received standard chemotherapy.

CHOP Plus Zevalin (REG) Therapy Shows Efficacy In Elderly Patients ...  -  Dec 25, 2006
Medical News Today (press release),...to treatment of elderly patients suffering from the most common type of aggressive NHL, Diffuse Large-B-cell Lymphoma (DLBCL)(1). Zevalin (90Y Ibritumomab ...

Addition of Zevalin to Transplant Chemotherapy Improves Survival ...  -  Dec 13, 2006
DG NewsORLANDO, FL -- December 13, 2006 -- The addition of yttrium 90 ibritumomab tiuxetan (Zevalin) to a standard condition regimen for patients undergoing ...

Fludara®-Novantrone® Induction and Zevalin® Consolidation ...  -  Dec 19, 2006
Cancer Consultants (press release),...a 100% complete response (CR) rate to induction therapy with oral Fludara (fludarabine) and Novantrone (mitoxantrone) (FM) followed by Zevalin in patients who ...

APS: CHOP Plus Zevalin(R) Therapy is Feasible, Tolerable and .....  -  Dec 10, 2006
ANP Pers Support,...achieved by the first-line treatment. These data are promising as they show Zevalin can. DLBCL patients. Elderly patients may be ...

Zevalin® Can Safely Be Given With High Dose BEAM with Autologous ...  -  Dec 18, 2006
Cancer Consultants (press release),Two studies presented at the 2006 meeting of the American Society of Hematology demonstrated that Zevalin (yttrium 90 ibritumomab tiuxetan) could be combined ...

CHOP Plus Zevalin(R) Therapy is Feasible, Tolerable and Shows ...  -  Dec 10, 2006
Earthtimes.org...totreatment of elderly patients suffering from the most common type ofaggressive NHL, Diffuse Large-B-cell Lymphoma (DLBCL)(1). Zevalin (90YIbritumomab Tiuxetan ...

(PRN) - Mitsubishi Motors Introduces Next-Generation 2008 Lancer . ...  -  Dec 11, 2006
Bolsamania.com,...[+]. (PRN) - CHOP Plus Zevalin(R) Therapy is Feasible, Tolerable and Shows Efficacy in Elderly Patients With Most Common Type of Aggressive NHL ... [+. ...

'Cancer made me realise that life is just so precious'  -  Dec 16, 2006
ic Wales,Sean, a South Wales Police constable and member of Llandaff North Rugby Club, was left to find thousands of pounds to pay for Zevalin, the drug needed to fight ...

MDS Reports Fourth Quarter and Fiscal 2006 Results  -  Dec 14, 2006
CNW Telbec (Communiqués de presse),Biogen-Idec has indicated that Zevalin(R) continues to under-perform their expectations and have also indicated that they are reviewing their options for this ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional